Concepedia

Emma Donald

ED

10

Publications

1.4K

Citations

10

H-Index

2005

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Manchester

Cancer Research UK Manchester Institute

Emma Donald is an author at AstraZeneca (United Kingdom) specializing in medicine, molecular diagnostics, and genetics.

Top concepts

Publications per year

2005–2021

10

Publications

10

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn et al. · Journal of Clinical Oncology · 2006 · 702 citations · Full text

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

Ruth Board, Andrew Wardley, J. Michael Dixon et al. · Breast Cancer Research and Treatment · 2010 · 199 citations · Full text

, , +11

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

Gillian Ellison, Emma Donald, Gael McWalter et al. · Journal of Experimental & Clinical Cancer Research · 2010 · 152 citations · Full text

An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting

Kōichi Goto, Miyako Satouchi, Genichiro Ishii et al. · Annals of Oncology · 2012 · 103 citations · Full text

, , +12

Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples

Shethah Morgan, Jessica Whiteley, Emma Donald et al. · Clinical Medicine Insights Pathology · 2012 · 70 citations · Full text

Rows per page

1–5 of 10